Literature DB >> 12955669

The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis.

Michael Haley1, Avi S Retter, Daniel Fowler, Jaun Gea-Banacloche, Naomi P O'Grady.   

Abstract

Intravenous immunoglobulin (IVIG) with high titers to West Nile virus was used as an adjuvant therapy for a patient with West Nile virus encephalitis that did not respond to supportive care. We present this case report and review the evidence supporting the use of high-titer IVIG.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12955669     DOI： 10.1086/377172

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  30 in total

Review 1.  West Nile virus: a growing concern?

Authors:  L Hannah Gould; Erol Fikrig
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 2.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

Review 3.  West Nile virus meningoencephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Nat Clin Pract Neurol       Date:  2006-05

4.  Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus.

Authors:  L Hannah Gould; Jianhua Sui; Harald Foellmer; Theodore Oliphant; Tian Wang; Michel Ledizet; Akikazu Murakami; Kristin Noonan; Cassandra Lambeth; Kalipada Kar; John F Anderson; Aravinda M de Silva; Michael S Diamond; Raymond A Koski; Wayne A Marasco; Erol Fikrig
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  West Nile virus-associated brachial plexopathy.

Authors:  Mandeep Chahil; Thy Phuong Nguyen
Journal:  BMJ Case Rep       Date:  2016-03-30

Review 6.  Progress on the development of therapeutics against West Nile virus.

Authors:  Michael S Diamond
Journal:  Antiviral Res       Date:  2009-06-06       Impact factor: 5.970

7.  Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile Virus.

Authors:  Jagadish Beloor; Nyree Maes; Irfan Ullah; Pradeep Uchil; Andrew Jackson; Erol Fikrig; Sang Kyung Lee; Priti Kumar
Journal:  Cell Host Microbe       Date:  2018-03-29       Impact factor: 21.023

Review 8.  Emerging Cases of Powassan Virus Encephalitis in New England: Clinical Presentation, Imaging, and Review of the Literature.

Authors:  Anne Piantadosi; Daniel B Rubin; Daniel P McQuillen; Liangge Hsu; Philip A Lederer; Cameron D Ashbaugh; Chad Duffalo; Robert Duncan; Jesse Thon; Shamik Bhattacharyya; Nesli Basgoz; Steven K Feske; Jennifer L Lyons
Journal:  Clin Infect Dis       Date:  2015-12-13       Impact factor: 9.079

9.  Neuromuscular Manifestations of Human West Nile Virus Infection.

Authors:  A Arturo Leis; Dobrivoje S Stokic
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.972

10.  Successful treatment with intravenous immunoglobulin of acute flaccid paralysis caused by west nile virus.

Authors:  Mohammad Sami Walid; Fade Aziz Mahmoud
Journal:  Perm J       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.